Table 4.
Depicting Odd Ratio (OR) and corresponding p-value of selected gene polymorphisms with CAD
MODEL | OR (95% CI) | p-value |
---|---|---|
ESR1 IVS1–397 T/C | ||
Co-dominant | ||
TC vs TT | 1.05 [0.79–1.41] | 0.7 |
CC vs TT | 1.17 [0.73–1.88] | 0.5 |
Dominant | ||
TC + CC vs TT | 1.07 [0.81–1.42] | 0.6 |
Recessive | ||
CC vs TC + TT | 3.39 [0.92–12.42] | 0.6 |
Allelic | ||
C vs T | 1.07 [0.87–1.31] | 0.5 |
ESR1- IVS1–351 A/G | ||
Co-dominant | ||
AG vs AA | 1.23 [0.89–1.70] | 0.2 |
GG vs AA | 1.93 [1.29–2.89] | 0.001* |
Dominant | ||
AG + GG vs AA | 1.40 [1.03–1.90] | 0.03* |
Recessive | ||
GG vs AG+ AA | 1.70 [1.20–2.40] | 0.003* |
Allelic | ||
G vs A | 1.37 [1.12–1.67] | 0.002* |
CETP-(C277T) (TaqIB) | ||
Co-dominant | ||
B1B2 vs B2B2 | 1.13 [0.82–1.57] | 0.4 |
B1B1 vs B2B2 | 1.25 [0.83–1.90] | 0.3 |
Dominant | ||
B1B2 + B1B1 vs B2B2 | 1.63 [0.85–1.59] | 0.3 |
Recessive | ||
B1B1 vs B1B2 + B2B2 | 1.16 [0.81–1.64] | 0.4 |
Allelic | ||
B1 vs B2 | 1.11 [0.91–1.35] | 0.3 |
MTHFR C677T | ||
Co-dominant | ||
CT vs CC | 4.61 [2.20–9.67] | 0.00001* |
TT vs CC | Not possible† | – |
Dominant | ||
CT + TT vs CC | Not possible† | – |
Recessive | ||
TT vs CT + CC | Not possible† | – |
Allelic | ||
T vs C | 5.36 [2.45–10.62] | < 0.0001* |
MTHFR G1793A | ||
Co-dominant | ||
GA vs GG | 1.29 [0.91–1.83] | 0.15 |
AA vs GG | Not possible† | – |
Dominant | ||
GA + AA vs GG | Not possible† | – |
Recessive | ||
AA vs GA+ GG | Not possible† | – |
Allelic | ||
A vs G | 1.37 [1.00–1.90] | 0.06 |
MS A2756G | ||
Co-dominant | ||
AG vs AA | 1.58 [1.16–2.14] | 0.003* |
GG vs AA | 3.90 [1.06–14.34] | 0.03* |
Dominant | ||
AG + GG vs AA | 1.64 [1.22–2.22] | 0.001* |
Recessive | ||
GG vs AG+ AA | 3.39 [0.93–12.42] | 0.1 |
Allelic | ||
G vs A | 1.57 [1.20–2.05] | 0.001* |
* Significant values